Umedzhon Gafarov

Umedzhon Gafarov

Auto-generated profile, based on publicly available information

Umedzhon Gafarov

Moscow Research and Clinical Center for Tuberculosis Control of the Moscow Government Department of Health; Moscow Regional Hospital named after Professor V.N. Rozanov

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2023 in Turkish Journal of Surgery
Verified
Journal Article
Open access
PDF file
DPDmitriy Plotkin
Dmitriy Plotkin
UGUmedzhon Gafarov
Umedzhon Gafarov
MRMikhail Reshetnikov
Mikhail Reshetnikov
SSSergey Aleksandrovich Sterlikov
Sergey Aleksandrovich Sterlikov
EBElena Bogorodskaya
Elena Bogorodskaya
Objective: Acute pancreatitis is common in HIV-infected patients; however, the causes and severity of pancreatitis in HIV-positive patients have a number of significant features that affect both the severity of destruction of the pancreas and the methods of diagnosis and treatment. Material and Methods: Anamnestic data, results of diagnosis and treatment of two groups of patients with acute pancreatitis were analyzed. The first group included 79 patients with acute pancreatitis combined with HIV infection who were admitted to the clinic for the period from 2017 to 2021. In people living with HIV, drugs and infectious agents caused acute pancreatitis in 11.4% and 24.1% of the cases, respectively. As our study showed, in patients with normal immune status, the drug etiology of pancreatitis prevailed in the structure of the causes of AP, in patients with immunodeficiency, infectious causes of pancreatitis were dominant. Results: According to the results of data analysis, it is clear that HIV infection is a factor that makes the course of pancreatitis about two times worse regardless of the presence of immunosuppression. The etiological structure of HIV-associated acute pancreatitis directly depends on the patient’s immune status and differs in many ways from that of HIV-negative patients or patients receiving ART. Conclusion: The severity of the disease and the risk of death remain high in acute pancreatitis caused by infectious agents against the background of immunosuppression.

14 February 2025 in HIV Infection and Immunosuppressive Disorders
Verified
Journal Article
Open access
PDF file
MRMikhail Reshetnikov
Mikhail Reshetnikov
SSSergey Aleksandrovich Sterlikov
Sergey Aleksandrovich Sterlikov
UGU. O. Gafarov
U. O. Gafarov
DPD. V. Plotkin
D. V. Plotkin
The aim: to determine the main risk factors and their impact on the development of tuberculous enterocolitis (TEC) in Moscow. Materials and methods. Risk factors for the development of intestinal tuberculosis were studied in 217 adult patients with a combination of respiratory tuberculosis and intestinal tuberculosis compared with 22 663 adult patients with respiratory tuberculosis without tuberculosis intestines registered in 2016–2023.Results and discussion. As a result of the calculations, the main risk factors for the development of tuberculous enterocolitis were immunosuppressive therapy (aOR 12.05; 95% CI 6.71–20.69), diabetes mellitus (aOR 9.06; 95% CI 4.45–16.81) and HIV infection (aOR 7.55; 95% CI 5,40–10,67). In our study, we were able to identify the main risk factors affecting the development of tuberculous enterocolitis and adapt the results obtained to the diagnostic search scheme in patients with generalized tuberculosis: the examination algorithm for such patients must necessarily include performing an abdominal CT scan with double contrast enhancement and colonoscopy with biopsy.Conclusion. Taking into account predictors of tuberculous enterocolitis and including them in clinical diagnostic algorithms can help in early diagnosis of the disease and avoid the appearance of its complicated forms.

30 September 2021 in Tuberculosis and socially significant diseases
Verified
Journal Article
Open access
PDF file
DPD. V. Plotkin
D. V. Plotkin
MRMikhail Reshetnikov
Mikhail Reshetnikov
TVTatiana Vinogradova
Tatiana Vinogradova
YZYu. R. Zyuzya
Yu. R. Zyuzya
UGU. O. Gafarov
U. O. Gafarov
ЮЗЮ. Р. Зюзя
Ю. Р. Зюзя
Animal modeling of tuberculosis is necessary to study the pathogenesis of the disease and the immune response. Attempts to simulate various models of pulmonary and extrapulmonary tuberculosis made on laboratory animals that are considered the most susceptible to tuberculosis infection. The simulation of extrapulmonary forms of tuberculosis has serious difficulties and the number of patented models is extremely limited. Due to the frequent cases of tuberculosis extrapulmonary manifestations among the cohort of patients with immunosuppressive state, it is necessary to study the pathogenesis and combined organ-lesions in abdominal tuberculosis, to develop possible options for conservative and surgical treatment. To do this, it is necessary to return to the modeling of a specific process and to the search for the optimal model animal. Materials and methods. We considered mice and rabbits as the optimal model. The first experimental infection was carried out on 5 male mice of the C57/Black6 line and 10 male rabbits of the Soviet Chinchilla breed, which were infected by intraperitoneal injection of a suspension of Mycobacterium tuberculosis. Results. No signs of tuberculous inflammation of the peritoneum and intestines found in any of the animal species. Generalized tuberculosis detected in all mice without the formation of a granulomatous process. In a case of the rabbits, four animals showed the complete absence of signs of tuberculosis, and the other six had a lesion of the lung tissue only, at that morphologically pulmonary tuberculosis was similar to human tuberculosis in many respects. Conclusion. The results of our experiment indicate the practicability of using rabbits for modeling abdominal tuberculosis, similar in its chronic course and morphological features to human tuberculosis.

13 August 2025 in Russian Journal of Gastroenterology, Hepatology, Coloproctology
Verified
Journal Article
Open access
PDF file
UGU. O. Gafarov
U. O. Gafarov
DPD. V. Plotkin
D. V. Plotkin
MRMikhail Reshetnikov
Mikhail Reshetnikov
NDN. O. Demchenkov
N. O. Demchenkov
AVA. A. Volkov
A. A. Volkov
EBE. M. Bogorodskaya
E. M. Bogorodskaya
Gastrointestinal hemorrhage is about 1.3 times more common in HIV-infected patients than in HIV-negative ones. At the same time the structural and etiological causes of hemorrhage in HIV differ in many ways from the main population which is undoubtedly due to the use of modern antiretroviral therapy, opportunistic infections and comorbidities. Aim: to study the factors which are aggravating the course and influencing the structure of gastrointestinal bleeding in patients with HIV infection on the background of immunosuppressive disorders in comparison with HIV-negative patients.Material and methods. To achieve this goal a multicenter retrospective cohort study of three groups of patients with gastrointestinal hemorrhage was conducted. Five hundred patients participated in the study: n = 111 — the main group (42 in Group 1 — HIV+, CD4+ > 200; 69 in Group 2 — HIV+, CD4+ < 200); n = 389 — in the control group (Group 3 — HIV-negative status).Results. It was found that the comparison groups differ in age, the presence of previous hematological pathology (anemia, thrombocytopenia) as well as the sources of gastrointestinal bleeding. It can be noted that in all comparison groups endoscopic hemostasis methods were effective in about half of the cases (50.0 %, 42.0 % and 49.7 %), in the remaining findings hemostatic therapy was effective and sufficient (47.6 %, 33.3 % and 39.7 %). Surgical treatment was much more often required (statistically significant) in the group of patients with low immune status (29.0 %), and the need for it was associated with “rare sources” of bleeding: tuberculous intestinal ulcers, cytomegalovirus intestinal ulcers and decomposing Kaposi’s sarcoma of various parts of the digestive tract. The overall survival rate of HIV-infected patients with low immune status and gastrointestinal bleeding was statistically lower than in HIV-negative patients or patients with satisfactory immune status.Conclusion. Gastrointestinal bleeding in HIV-positive patients has a number of significant features, that directly affect severity of blood loss, treatment methods and patient survival.

20 March 2025 in Bulletin of the Medical Institute "REAVIZ" (REHABILITATION, DOCTOR AND HEALTH)
Verified
Journal Article
Open access
PDF file
VMV. M. Manuylov
V. M. Manuylov
ASA. N. Shcherbyuk
A. N. Shcherbyuk
DTD. A. Tsarev
D. A. Tsarev
YZYu. I. Zakharov
Yu. I. Zakharov
YNYa. E. Nemstsveridze
Ya. E. Nemstsveridze
ЯНЯ. Э. Немсцверидзе
Я. Э. Немсцверидзе
Introduction. Cholecystoduodenal fistula is a rare complication of cholelithiasis and extremely rarely manifests as massive bleeding from the upper gastrointestinal tract. Only 15 similar clinical cases have been described in the world literature. Objective: To present a clinical case of a biliodigestive fistula complicated by upper gastrointestinal bleeding, and to analyze the features of diagnosis and treatment of this pathology. Materials and methods. A clinical case of a 62-year-old patient with cholelithiasis complicated by cholecystoduodenal fistula and massive gastrointestinal bleeding is described. An analysis of literature data with systematization of 15 similar cases was conducted. Results. A patient with a known history of cholelithiasis and biliodigestive fistula developed massive bleeding from the upper gastrointestinal tract with hemorrhagic shock. Endoscopic examinations revealed a fixed hemorrhagic clot and a duodenal bulb ulcer. Despite conservative therapy and endoscopic hemostasis, on the 8th day, rebleeding occurred requiring emergency surgical intervention. Intraoperatively, cholecystoduodenal and cholecystotransverse fistulas with ongoing bleeding were identified. A 2/3 gastric resection with Roux-en-Y reconstruction, cholecystectomy, and right hemicolectomy were performed. Conclusion. Cholecystoduodenal fistula complicated by bleeding requires surgical treatment, as significant bleeding from large arteries is rarely eliminated by conservative treatment or endoscopic hemostasis. The presented case is the 16th in world surgical practice, which emphasizes the need for further study of this pathology and the development of effective treatment methods.